GM067386/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	1
2009	2
2011	4
2012	5
2013	2
2015	2
2016	2
2017	1
2018	1
2019	1
2020	2
2024	0

1

Immunocytokines for cancer treatment: past, present and future.

Neri D, Sondel PM. Neri D, et al. Curr Opin Immunol. 2016 Jun;40:96-102. doi: 10.1016/j.coi.2016.03.006. Epub 2016 Apr 6. Curr Opin Immunol. 2016. PMID: 27060634 Free PMC article. Review.

2

Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity.

Alderson KL, Sondel PM. Alderson KL, et al. J Biomed Biotechnol. 2011;2011:379123. doi: 10.1155/2011/379123. Epub 2011 May 24. J Biomed Biotechnol. 2011. PMID: 21660134 Free PMC article. Review.

3

Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma.

Voeller J, Sondel PM. Voeller J, et al. J Pediatr Hematol Oncol. 2019 Apr;41(3):163-169. doi: 10.1097/MPH.0000000000001369. J Pediatr Hematol Oncol. 2019. PMID: 30897608 Free PMC article. Review.

4

The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.

Yamane BH, Hank JA, Albertini MR, Sondel PM. Yamane BH, et al. Expert Opin Investig Drugs. 2009 Jul;18(7):991-1000. doi: 10.1517/13543780903048911. Expert Opin Investig Drugs. 2009. PMID: 19548853 Free PMC article. Review.

5

Enhancing Cancer Immunotherapy Via Activation of Innate Immunity.

Goldberg JL, Sondel PM. Goldberg JL, et al. Semin Oncol. 2015 Aug;42(4):562-72. doi: 10.1053/j.seminoncol.2015.05.012. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320061 Free PMC article. Review.

6

NK cell-based immunotherapies in Pediatric Oncology.

McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. McDowell KA, et al. J Pediatr Hematol Oncol. 2015 Mar;37(2):79-93. doi: 10.1097/MPH.0000000000000303. J Pediatr Hematol Oncol. 2015. PMID: 25590232 Free PMC article. Review.

7

Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.

Albertini MR, Hank JA, Gadbaw B, Kostlevy J, Haldeman J, Schalch H, Gan J, Kim K, Eickhoff J, Gillies SD, Sondel PM. Albertini MR, et al. Cancer Immunol Immunother. 2012 Dec;61(12):2261-71. doi: 10.1007/s00262-012-1286-5. Epub 2012 Jun 8. Cancer Immunol Immunother. 2012. PMID: 22678096 Free PMC article. Clinical Trial.

8

Antibody-based immunotherapy in high-risk neuroblastoma.

Johnson E, Dean SM, Sondel PM. Johnson E, et al. Expert Rev Mol Med. 2007 Dec 17;9(34):1-21. doi: 10.1017/S1462399407000518. Expert Rev Mol Med. 2007. PMID: 18081947 Review.

9

Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.

Koehn TA, Trimble LL, Alderson KL, Erbe AK, McDowell KA, Grzywacz B, Hank JA, Sondel PM. Koehn TA, et al. Front Pharmacol. 2012 May 16;3:91. doi: 10.3389/fphar.2012.00091. eCollection 2012. Front Pharmacol. 2012. PMID: 22623917 Free PMC article.

10

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites.

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Morris ZS, et al. Cancer Immunol Res. 2018 Jul;6(7):825-834. doi: 10.1158/2326-6066.CIR-17-0353. Epub 2018 May 10. Cancer Immunol Res. 2018. PMID: 29748391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year